First U.S. Clinical Implantations of MICRODEEP® PIXEL Depth Electrodes

Pioneering High-Resolution Intracranial Mapping in the U.S. DIXI medical is proud to announce the first U.S. clinical applications of the next-generation MICRODEEP® PIXEL depth electrodes. These landmark procedures were conducted at three premier epilepsy centers, marking a significant step forward in SEEG precision and surgical planning for complex epilepsy cases. Global Milestones in Clinical Use:. Rush University Medical Center: Dr. Arka Mallela performed the first-ever clinical implantation of the 18-contact PIXEL electrode , achieving high-quality, high-resolution signals for thalamic and insular mapping., UCHealth University of Colorado: Dr. Daniel Kramer completed the first 18-contact implantation in Colorado, reinforcing the hospital's leadership in advanced SEEG technologies., UC Davis Health: Dr. David Brandman achieved a global first by implanting the 15-contact MICRODEEP® PIXEL electrode , expanding the range of high-definition monitoring tools available to clinicians. Advancing Precision in Epilepsy Surgery. The PIXEL platform is specifically designed to provide higher-resolution intracranial mapping. By enabling more accurate localization in challenging areas like the thalamus and insula, these electrodes help surgical teams pinpoint seizure origins with unprecedented clarity. A Commitment to Innovation. “These milestone procedures reflect the growing momentum behind high-definition intracranial monitoring,” says Krisahn Gren, DIXI medical VP of Sales – US. This launch underscores our commitment to providing clinicians with the most advanced tools to improve outcomes for patients with drug-resistant epilepsy.